US Patent Issued to Arena Pharmaceuticals on Aug. 5 for "Methods of treating conditions related to the S1P 1 receptor" (California, Virginia Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,071, issued on Aug. 5, was assigned to Arena Pharmaceuticals Inc. (New York).

"Methods of treating conditions related to the S1P 1 receptor" was invented by Alan Glicklich (La Jolla, Calif.), Maria Matilde Sanchez Kam (Alexandria, Va.) and William R. Shanahan (Del Mar, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods of treatment of a sphingosine 1-phosphate subtype 1 (S1P1) receptor-associated disorder comprising prescribing and/or administering to an individual in need thereof a standard dose of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta [b]indol-3-yl)acetic acid (Compound 1), or a p...